George Medicines

Developer of single-pill combination treatments for cardiometabolic diseases

placeLondon, England, United Kingdom calendar_todayFounded 2016 groups2 employees language george-medicines.com

Registered entities

Social engagement

Social engagement: 2.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include Brandon BioCatalyst.

Investor typeCountShare
Venture capital2100%

Recent activity

29 Jun 2026
Leadership hire
Senior Vice President of Supply Chain & Technical Operations
23 Jun 2026
Event
World Stroke Organization and World Hypertension League webinar on bloodPressure management intracerebralHemorrhage
17 Jun 2026
Event
webinar
Coming soon